Nerve Tape® Study led by Top Surgeons Receives Distinction
Atlanta, GA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- BioCircuit Technologies, an NIH-supported company in Atlanta, GA, recently announced the publication of an independent study assessing Nerve Tape, the first device for sutureless nerve repair.
- Atlanta, GA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- BioCircuit Technologies, an NIH-supported company in Atlanta, GA, recently announced the publication of an independent study assessing Nerve Tape, the first device for sutureless nerve repair.
- Led by Dr. Kyle Eberlin, Program Director of MGH Harvard Plastic Surgery Residency Program and President-Elect, American Association for Hand Surgery, the study was performed by a team of internationally recognized nerve surgeons and surgeon trainees from top institutions.
- The surgeons executed 144 cadaveric nerve repairs, comparing the performance of Nerve Tape with traditional microsuture repair techniques.
- Nerve Tape also demonstrated superior repair quality, with 97% of repairs achieving clinically acceptable nerve end alignment.